- Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
- Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
- Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
Key statistics
On Friday, Aethlon Medical Inc (AEMD:NAQ) closed at 1.18, 6.31% above its 52-week low of 1.11, set on May 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.56 |
---|---|
High | 1.79 |
Low | 1.11 |
Bid | 1.14 |
Offer | 1.15 |
Previous close | 1.18 |
Average volume | 2.00m |
---|---|
Shares outstanding | 2.62m |
Free float | 2.45m |
P/E (TTM) | -- |
Market cap | 3.09m USD |
EPS (TTM) | -5.03 USD |
Data delayed at least 15 minutes, as of May 10 2024 21:00 BST.
More ▼